Changeflow GovPing Healthcare & Life Sciences Digital Health Parent-Training RCT for Autistic...
Routine Notice Added Final

Digital Health Parent-Training RCT for Autistic Children

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NIH has registered pilot randomized controlled trial NCT07551752, evaluating a self-directed digital health parent-training program (OPT-In-Early) teaching naturalistic developmental behavioral intervention strategies to parents of young children with autism spectrum disorder or social communication delays. The study plans to enroll 50 children, including both those already diagnosed and those screening positive but awaiting formal evaluation, to test preliminary efficacy against treatment as usual and explore parent engagement willingness.

“The proposed pilot randomized controlled trial (RCT) will test a revised self-directed parent-training program, that teaches parents naturalistic developmental behavioral intervention (NDBI) strategies, which have proven effective for young children with autism.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This document registers a new pilot randomized controlled trial on ClinicalTrials.gov under identifier NCT07551752. The study will evaluate a revised self-directed parent-training program called OPT-In-Early, which teaches parents naturalistic developmental behavioral intervention strategies. The trial will include children with confirmed autism diagnoses and children who screen positive but lack formal evaluation, enabling study of earlier intervention pathways.

For clinical investigators and healthcare providers, this trial represents an emerging evidence base for digital health interventions as scalable alternatives to traditional autism-specific services. The focus on self-directed programs without provider coaching may inform future service-delivery models addressing access barriers including diagnosis delays, waitlists, travel distances, and costs.

Archived snapshot

Apr 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

A Digital Health Parent-Training Intervention for Children With Social Communication Delays

N/A NCT07551752 Kind: NA Apr 27, 2026

Abstract

Early intervention, during a time of optimal brain plasticity, is critical for autistic children to develop functional skills such as communication and daily living abilities. However, many families face barriers to accessing timely autism-specific services due to delays in autism diagnosis (which is often a prerequisite to autism-specific intervention), long waitlists, high costs, and the necessity to travel far distances to service providers. Self-directed parent-mediated digital health interventions (i.e., programs that parents complete online without provider coaching or feedback) offer a scalable solution to reduce challenges accessing intervention by providing evidence-based strategies that parents can implement without relying on traditional service pathways. The proposed pilot randomized controlled trial (RCT) will test a revised self-directed parent-training program, that teaches parents naturalistic developmental behavioral intervention (NDBI) strategies, which have proven effective for young children with autism. The study will include young children who have already been diagnosed with autism and those who screen positive on an autism screener but have not yet been evaluated, enabling earlier intervention before a formal diagnosis. The study will also explore parents' willingness to engage in the intervention. The specific research aims are: (1) test the preliminary efficacy of the parent-training program vs. treatment as usual (TAU) for 50 children with autism...

Conditions: Autism Spectrum Disorder, Social Communication Delay

Interventions: Online Parent Training in Early Behavioral Intervention (OPT-In-Early)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07551752

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Clinical research
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Healthcare Clinical Operations

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!